Melissa D Meredith, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd Ste 106, Newark, DE 19713 Phone: 302-454-9800 Fax: 302-454-6446 |
Lindsay Dormer Robinson, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2600 Glasgow Ave Ste 207, Newark, DE 19702 Phone: 028-321-1243 |
Angela M Madariaga, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4745 Ogletown Stanton Rd Ste 105, Newark, DE 19713 Phone: 302-368-3257 |
Alexandrea Caroline Russell, CNM, WHNP-BC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4745 Ogletown-stanton Rd, Map 1, Suite 200, Newark, DE 19713 Phone: 302-454-9800 |
News Archive
Emerging data clarifying the risks of insufficient thyroid activity during pregnancy on the health of the mother and fetus, and on the future intellectual development of the child, have led to new clinical guidelines for diagnosing and managing thyroid disease during this critical period.
While AHIMA continues to applaud federal government support for the ideal of protecting patients' health information rights, the proposed rule making for HIPAA privacy, security and enforcement by HHS has a number of requirements that we do not believe the industry is ready to undertake; especially as it gears up for Meaningful Use. Today AHIMA is releasing its recommendations to the HHS Office of Civil Rights (OCR) that speak to the issues we believe are most critical to the patients of America, the healthcare industry and the best practice of health information management.
Chemists at the University of Waterloo, SCIEX and Pfizer have discovered a new way to help the pharmaceutical industry identify and test new drugs, which could revolutionize drug development, and substantially reduce the cost and time drugs need to reach their market.
Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.
Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company's first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).
› Verified 3 days ago